Department of Neurology and Neurosurgery, McGill University, Montreal, QC H3A 2B4, Canada.
Clinical Research Unit, The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, QC H3A 2B4, Canada.
Brain. 2024 Aug 1;147(8):2595-2597. doi: 10.1093/brain/awae181.
This scientific commentary refers to ‘Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s Disease Study’ by Westenberger (https://doi.org/10.1093/brain/awae188) and ‘Parkinson’s disease variant detection and disclosure: PD GENEration, a North American study’ by Cook . (https://doi.org/10.1093/brain/awae142).
本科学评论提到了 Westenberger 的“基因靶向试验时代遗传检测的相关性：罗斯托克帕金森病研究”（https://doi.org/10.1093/brain/awae188）和 Cook 的“帕金森病变异检测和披露：北美的 PD GENEration 研究”（https://doi.org/10.1093/brain/awae142）。
